Rn. Puri et Rw. Colman, IMMUNOAFFINITY METHOD TO IDENTIFY AGGREGIN, A PUTATIVE ADP-RECEPTOR IN HUMAN BLOOD-PLATELETS, Archives of biochemistry and biophysics, 347(2), 1997, pp. 263-270
The ADP-receptor on the surface of human platelets and cells of megaka
ryocytic lineage has been classified as P2T purinergic receptor for wh
ich ADP is an agonist and ATP is an antagonist. Although it is one of
the earliest identified of the important cellular receptors, it has ne
ither been purified nor cloned, We have developed an immunoaffinity me
thod for rapidly identifying the platelet ADP-receptor and this method
can be extended to the purification of the receptor. A polyclonal ant
ibody to glutamate dehydrogenase (GDH) covalently modified by 5'-p-flu
orosulfonylbenzoyladenosine (FSBA) recognized neither FSBA nor glutama
te dehydrogenase. Immunoblot of the gel obtained by sodium dodecyl sul
fate-polyacrylamide gel electrophoresis of solubilized FSBA-labeled pl
atelets showed the presence of a protein band at 100 kDa and this band
was absent in the immunoblots of platelets that were preincubated wit
h ADP and ATP or covalently modified by the chemically reactive ADP-af
finity analogs, 2- and -bromo-2,3-dioxobutylthio)adenosine-5'-diphosph
ate (2- and 8-BDB-TADP) and 2-(3-bromo-2-oxopropylthio) adenosine-5'-d
iphosphate (2-BOP-TADP), prior to treatment with FSBA. FSBA as well as
2- and 8-BDB-TADP and 2-BOP-TADP have been previously shown to inhibi
t ADP-induced platelet responses by selectively and covalently modifyi
ng aggregin (100 kDa), an ADP-receptor in intact human blood platelets
. The results show that polyclonal antibody to FSBA-labeled GDH is cap
able of recognizing FSBA-labeled aggregin on platelets and, thus, coul
d be used to purify aggregin by immunoaffinity column chromatography,
The immunoaffinity method was found to be far more sensitive than the
radiochemical methods to identify aggregin previously developed in our
laboratory. Since FSBA is also capable of reacting with enzymes that
require ATP for their catalytic function, the polyclonal antibody may
be used to identify and purify other P2-type purinergic receptors that
require binding of ATP before eliciting cellular responses. (C) 1997
Academic Press.